欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/V/0286/001
药品名称EURICAN DAPPi2-LMULTI
活性成分
    • canine adenovirus 0.0 CCID50
    • canine distemper virus 0.0 CCID50
    • canine parainfluenza virus 0.0 CCID50
    • canine parvovirus 0.0 CCID50
    • leptospira interrogans serogroup canicola 0.0 %
    • leptospira interrogans serogroup icterohaemorragiae 0.0 %
    • Leptospira kirschneri serogroup Grippotyphosa 0.0 %
剂型Lyophilisate and solvent for suspension for injection
上市许可持有人MERIAL
参考成员国 - 产品名称France (FR)
EURICAN DAPPI-L MULTI
互认成员国 - 产品名称
    • Germany (DE)
      Eurican DHPPi-Lmulti
    • Denmark (DK)
      Eurican DHPPi2-Lmulti
    • Belgium (BE)
      Eurican DAPPi-Lmulti
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Eurican SHPPi2Lmulti, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Eurican DHPPi2 -Lmulti
    • Lithuania (LT)
    • Estonia (EE)
      Eurican DAPPi-Lmulti
    • Hungary (HU)
      Eurican DHPPi2-L3 vakcina A.U.V.
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2015/07/22
最近更新日期2024/07/04
药物ATC编码
    • QI07AI02 live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase